Filing Details
- Accession Number:
- 0001181431-13-003359
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-01-16 16:07:49
- Reporting Period:
- 2013-01-14
- Filing Date:
- 2013-01-16
- Accepted Time:
- 2013-01-16 16:07:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 722104 | Savient Pharmaceuticals Inc | SVNT | Medicinal Chemicals & Botanical Products (2833) | 133033811 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1250318 | K Philip Yachmetz | Savient Pharmaceuticals, Inc. 400 Crossing Blvd. Bridgewater NJ 08807 | Svp, General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock $.01 Par Value Per Share | Disposition | 2013-01-14 | 1,283 | $1.14 | 334,201 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- These shares were sold automatically pursuant to a binding contract under Rule 10b5-1 of the Securities Exchange Act of 1934 to cover tax witholding obligations in connection with the vesting of restricted stock granted on February 15, 2008
Billionaire Hedge Funds
